HIV PrEP Update for GPs and Practice Nurses

A landmark in HIV prevention drugs, PrEP (tenofovir with emtricitabine) is now approved for use on the Pharmaceutical Benefits Scheme, thereby providing broader access for any doctor, general practitioner, and endorsed nurse practitioner to be able to prescribe PrEP to an eligible Australian resident who holds a current Medicare card

This training will provide GPs, Nurses, and Health Professionals working in primary care an update on strategies available for the prevention of HIV transmission, focusing on prevention particularly pre-exposure prophylaxis (PrEP).

At the end of this update, participants will be able to:

  • Identify priority populations for testing
  • Understand HIV epidemiology
  • Understand what Anti-Retroviral Therapy is and how to access it
  • Comprehend PrEP safety efficacy and usage data
  • Understand effectiveness of PrEP
  • Understand difference HIV prevention strategies including PrEP and PostExposure Prophylaxis (PEP)
  • Explain to patients what PrEP/PEP is and how to access it
  • Implement a rage of HIV Prevention Strategies


More Info:

June 19, 2018 at 6pm - 9pm
Rydges Fortitude Valley
601 Gregory Ter
Fortitude Valley, Queensland 4006
Google map and directions

Will you come?

Be the first to comment

Please check your e-mail for a link to activate your account.